Results 41 to 50 of about 36,296 (116)

Post-translational modifications in prion diseases. [PDF]

Front Mol Neurosci
Bizingre C, Bianchi C, Baudry A, Alleaume-Butaux A, Schneider B, Pietri M.   +5 more
europepmc   +1 more source

Proteostasis unbalance in prion diseases: Mechanisms of neurodegeneration and therapeutic targets. [PDF]

Front Neurosci, 2022
Thellung S, Corsaro A, Dellacasagrande I, Nizzari M, Zambito M, Florio T.   +5 more
europepmc   +1 more source

Abnormal Expression of Proteolytic Stress-Related Proteins and Protective Effect of Fibrinolytic Enzymes in Prion Diseases. [PDF]

Transbound Emerg Dis
Kim YC, Won SY, Jeong BH.
europepmc   +1 more source

Prion Pathogenesis Revealed in a Series of the Special Issues "Prions and Prion Diseases". [PDF]

Int J Mol Sci, 2022
Sakaguchi S.
europepmc   +1 more source

Prion and Prion Diseases

, 2020
This review article provides the main information regarding a specific category of infectious diseases of animals and humans, the so-called transmissible spongiform encephalopathies, or prion infections. In a brief introduction explains the need for lighting issues in relation to environmental, veterinary public health importance in traffic and the ...
openaire   +1 more source

Reactive microglia partially envelop viable neurons in prion diseases. [PDF]

J Clin Invest
Makarava N, Safadi T, Bocharova O, Mychko O, Pandit NP, Molesworth K, Baiardi S, Zhang L, Parchi P, Baskakov IV.   +9 more
europepmc   +1 more source

Gene expression and epigenetic markers of prion diseases. [PDF]

Cell Tissue Res, 2023
Viré EA, Mead S.
europepmc   +1 more source

Prion diseases disrupt glutamate/glutamine metabolism in skeletal muscle. [PDF]

PLoS Pathog
Caredio D, Koderman M, Frontzek KJ, Sorce S, Nuvolone M, Bremer J, Mariutti G, Schwarz P, Madrigal L, Mitrovic M, Sellitto S, Streichenberger N, Scheckel C, Aguzzi A.   +13 more
europepmc   +1 more source

Irisin regulates oxidative stress and mitochondrial dysfunction through the UCP2-AMPK pathway in prion diseases. [PDF]

Cell Death Dis
Wen P, Sun Z, Yang D, Li J, Li Z, Zhao M, Wang D, Gou F, Wang J, Dai Y, Zhao D, Yang L.   +11 more
europepmc   +1 more source

β-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer's and Parkinson's disease. [PDF]

Alzheimers Res Ther
Xu B, Xiao K, Jia X, Cao R, Liang D, A R, Zhang W, Li C, Gao L, Chen C, Shi Q, Dong X.   +11 more
europepmc   +1 more source